SciELO - Scientific Electronic Library Online

 
vol.24 issue4Unfrequently opportunistic infection in lupus erythematosus with inmunosuppresive treatmentCrohn’s disease: is still the reason of fever of unknown origin? author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Anales de Medicina Interna

Print version ISSN 0212-7199

Abstract

CALLEJA SUBIRAN, M. C.; HERNANDEZ GUTIERREZ, F. J.; LOPEZ ELZAURDIA, C.  and  REVESTIDO GARCIA, R.. Liposarcoma histologic subtypes: four cases reports. An. Med. Interna (Madrid) [online]. 2007, vol.24, n.4, pp.179-184. ISSN 0212-7199.

The liposarcoma is a malignant tumor of mesodermic origin derived of the adipose tissue. Liposarcoma's types, according to his histological diagnosis, are: mixoide, pleomorphic, well differentiated and dedifferentiated. It can get to reach enormous proportions, mainly when it is located at abdominal level. His treatment is the radical surgery, it is possible, together with radiation therapy and/or chemotherapy. Four patients diagnosed of liposarcoma are shown up, a case of liposarcoma well differentiated, another case of liposarcoma pleomorphic and two cases about liposarcoma mixoide; with the characteristic that one of these two cases presented a local recidivation with a dediferenciation of itself. The evolution of the four cases, was in a different way. So, their prognosis is going to depend on their histopathologic variety and on a possible multicentricidad that is going to difficult the complete radical surgical exeresis.

Keywords : Liposarcoma; Well-differentiated; Myxoid; Pleomorphic and dedifferentiated.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License